Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Generated Narrative: Ingredient
Resource Ingredient "fc09842a-8f71-48f2-9f9f-ff2441b2eb6f"
Profile: Drug Product Component
status: draft
role: Active Ingredient (PQ-CMC-FDA Temporary Codes#C82533)
substance
Codes
Reference urn:uuid:2d70d504-8cc6-4282-81d4-b20b0a98b78b Strengths
Extension Presentation[x] TextPresentation 200 mg (Details: http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy code C28253 = 'mg')/1 [arb'U] (Details: http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy code C75765 = '[arb'U]') 200mg